Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | LM2219 | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | A5T73 | IM / LA |
The Comirnaty COVID-19 vaccine administered to the patient had previously been subject to a temperature excursion in January 2025, when a different pharmacist in charge (PIC) was overseeing operations. The vial was removed from refrigeration and left at room temperature for one to two days due to its upcoming expiration date of March 29, 2025. It was later returned to refrigeration for potential return but was administered to a patient on March 3, 2025. Patient also received Shingrix along with Comirnaty.
NKDA